Aaron Kimball - 18 Jan 2022 Form 4 Insider Report for Zymergen Inc.

Signature
/s/ Mina Kim, attorney-in-fact
Issuer symbol
N/A
Transactions as of
18 Jan 2022
Net transactions value
-$259,080
Form type
4
Filing time
20 Jan 2022, 16:42:00 UTC
Previous filing
07 Dec 2021
Next filing
03 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZY Common Stock Sale $259,080 -50,000 -5.9% $5.18 795,283 18 Jan 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2021.
F2 Transaction executed in multiple trades at prices ranging from $5.02 to $5.42 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.